SCHEMBL622528

SCHEMBL622528

OB1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5576712 0.90
SCHEMBL27696073 0.67
SCHEMBL5179366 0.62
SCHEMBL752992 0.62
SCHEMBL16341769 0.61
SCHEMBL6240283 0.60 ALDH1A1 (0.36)
SCHEMBL7124801 0.60
SCHEMBL18292088 0.58 ALDH1A1 (0.33)
SCHEMBL15139518 0.56
SCHEMBL31174151 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250064838-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2025-02-27 US disclosed
US-12171772-B2 Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives MELINTA SUBSIDIARY CORP. (US) 2024-12-24 US disclosed
US-20230277571-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2023-09-07 US disclosed
US-11684629-B2 Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives MELINTA SUBSIDIARY CORP. (US) 2023-06-27 US disclosed
US-20220125813-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2022-04-28 US disclosed
EP-3666778-B1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF MELINTA THERAPEUTICS INC (US) 2021-11-10 EP disclosed
US-11090319-B2 Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives MELINTA SUBSIDIARY CORP. (US) 2021-08-17 US disclosed
US-20200222434-A1 THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES MELINTA SUBSIDIARY CORP. 2020-07-16 US disclosed
EP-3666778-A1 A CRYSTALLINE CYCLIC BORONIC ACID ESTER DERIVATIVE, METHOD FOR THE PREPARATION AND THERAPEUTIC USES THEREOF Rempex Pharmaceuticals, Inc. (US) 2020-06-17 EP disclosed
US-10639318-B2 Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives REMPEX PHARMACEUTICALS, INC. (US) 2020-05-05 US disclosed
US-20160220591-A1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF MELINTA SUBSIDIARY CORP. 2016-08-04 US disclosed
US-9296763-B2 Cyclic boronic acid ester derivatives and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2016-03-29 US disclosed
US-20150119363-A1 METHODS OF TREATING BACTERIAL INFECTIONS Rempex Pharmaceuticals, Inc.. (US) 2015-04-30 US disclosed
EP-2814483-A2 METHODS OF TREATING BACTERIAL INFECTIONS Rempex Pharmaceuticals, Inc. (US) 2014-12-24 EP disclosed
US-8680136-B2 Cyclic boronic acid ester derivatives and therapeutic uses thereof REMPEX PHARMACEUTICALS, INC. (US) 2014-03-25 US disclosed
US-20130345172-A1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2013-12-26 US disclosed
WO-2013122888-A2 METHODS OF TREATING BACTERIAL INFECTIONS REMPEX PHARMACEUTICALS, INC. (US) 2013-08-22 WO disclosed
EP-2603514-A1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF Rempex Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
WO-2012021455-A1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
US-20120040932-A1 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF REMPEX PHARMACEUTICALS, INC. (US) 2012-02-16 US disclosed